Ottawa – November 7, 2023 – The Canadian Centre for Ethics in Sport (CCES) announced today that Mohamed Aagab, an athletics athlete, received a three-year sanction for an anti-doping rule violation. The athlete’s urine sample, collected in competition on May 7, 2023, revealed the presence of recombinant erythropoietin (rEPO), a prohibited peptide hormone.
On October 3, 2023, the athlete signed an Early Admission and Acceptance Agreement, thereby admitting to the violation and accepting the asserted period of ineligibility and all other consequences. As a result, the otherwise applicable four-year period of ineligibility was reduced by one year in accordance with Canadian Anti-Doping Program (CADP) rule 10.8.1. Because a provisional suspension was imposed on the athlete, their three-year sanction terminates on September 11, 2026.
Continue reading: www.cces.ca/news/athletics-athlete-suspended-presence-recombinant-erythropoietin